de Laat, Vincent https://orcid.org/0000-0003-0252-1179
Topal, Halit
Spotbeen, Xander
Talebi, Ali
Dehairs, Jonas https://orcid.org/0000-0002-6789-2264
Idkowiak, Jakub
Vanderhoydonc, Frank
Ostyn, Tessa
Zhao, Peihua
Jacquemyn, Maarten https://orcid.org/0000-0003-2626-4189
Wölk, Michele https://orcid.org/0000-0001-5558-4582
Sablina, Anna
Augustyns, Koen https://orcid.org/0000-0002-5203-4339
Vanden Berghe, Tom
Roskams, Tania
Daelemans, Dirk https://orcid.org/0000-0001-7092-1153
Fedorova, Maria https://orcid.org/0000-0002-4692-3885
Topal, Baki https://orcid.org/0000-0002-2687-7535
Swinnen, Johannes V. https://orcid.org/0000-0002-7720-5077
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek
Stichting Tegen Kanker
Kom op tegen Kanker - Stand Up to Cancer Flanders
Article History
Received: 12 April 2023
Accepted: 26 September 2024
First Online: 2 October 2024
Competing interests
: T.V.B. and K.A. hold patents US9862678, WO2016075330, EP3218357, and WO2019154795 related to ferrostatin-1 analogs. The remaining authors declare no competing interests.